Chikungunya fever, Hong Kong [2]

Emerging Infectious Diseases

Volumn 12, Issue 11, 2006, Pages 1790-1792

  Lee, Nelson ^a   Wong, Chun K ^a   Lam, Wai Y ^a   Wong, Ann ^b   Lim, Wilina ^b   Lam, Christopher W K ^a   Cockram, Clive S ^a   Sung, Joseph J Y ^a   Chan, Paul K S ^a   Tang, Julian W ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Department of Health ^*  (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

CHIKUNGUNYA ALPHAVIRUS; CHINA; FEVER; HUMAN; LETTER; MYALGIA; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYMPTOMATOLOGY; VIRUS DETECTION;

EID: 33750570862     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1211.060574     Document Type: Letter

References (10)

1. Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 2006;3:e263.
2. Laras K, Sukri NC, Larasati RP, Bangs MJ, Kosim R, Djauzi, WT, et al. Tracking the re-emergence of epidemic chikungunya virus in Indonesia. Trans R Soc Trop Med Hyg. 2005;99:128-41.
3. Lloyd G. Alphaviruses. In: Zuckerman AJ, Banatvala JE, Pattison JR, Griffiths PD, Schoub BD, editors. Principles and practice of clinical virology. 5th ed. Chichester (UK): John Wiley & Sons Ltd; 2004. p. 517-9.
4. Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004;136:95-103.
5. Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J, et al. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med. 2005;171:850-7.
6. Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet. 2004;363:617-9.
7. Avila-Aguero ML, Avila-Aguero CR, Um SL, Soriano-Fallas A, Canas-Coto A, Yan SB. Systemic host inflammatory and coagulation response in the Dengue virus primoinfection. Cytokine. 2004;27:173-9.
8. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A, et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol. 1999;59:329-34.
9. Briolant S, Garin D, Scaramozzino N, Jouan A, Crance JM. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-alpha and ribavirin combination. Antiviral Res. 2004;61:111-7.
10. Ajariyakhajorn C, Mammen MP Jr, Endy TP, Gettayacamin M, Nisalak A, Nimmannitya S, et al. Randomized, placebo-controlled trial of nonpegylated and pegylated forms of recombinant human alpha interferon 2a for suppression of dengue virus viremia in rhesus monkeys. Antimicrob Agents Chemother. 2005;49:4508-14.